92510:RISPERIDONE (RISPERDAL) and METABOLITE

Print View Attached Docs:
92510:RISPERIDONE (RISPERDAL) and METABOLITE
Alias Names: RISPERDAL
Methodology: High Performance Liquid Chromatography/Mass Spectrometry (HPLC/MS)
Edit Date: 8/7/2009
Performed: Monday, Wednesday, Friday
Released: 72 hours after setup at PeaceHealth Laboratories’ reference lab
CPT Code: 82542-90
Specimen Collection Details
Collection: One 5 mL red top tube. Do not use a serum separator tube (SST). Also acceptable: One 4 mL green top tube (heparin) or one 4 mL lavender top tube (EDTA). Do not use a plasma separator tube (PST).
Handling: Allow to clot, centrifuge and immediately separate serum or plasma from cells and pour into a plastic vial. Refrigerate.
Stability: Specimen stable 14 days at ambient temperature, 14 days refrigerated, or 7 months frozen.
Standard Volume: 2 mL serum or plasma.
Minimum Volume: 0.7 mL serum or plasma.
Transport: Refrigerated.
Rejection Criteria: Serum separator tube (SST) or plasma separator tube (PST).

No therapeutic or toxic range has been established. Risperidone and the 9-hydroxyrisperidone metabolite are equally active and the total drug concentration is important. At doses of 2-16 mg/d, steady-state values of 10-120 ng/mL of total drug were seen.

PeaceHealth Laboratories